4.5 Article

The impact of COVID-19 infection before the vaccination era on the hospitalized patients requiring hemodialysis: a single-center retrospective cohort

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Spectrum, Outcomes, and Mortality Predictors of Acute Kidney Injury among Non-COVID-19 Patients during COVID-19 Pandemic: Data from Four Intensive Care Units

Bhupinder Singh et al.

Summary: Compared to the pre-COVID era, community-acquired acute kidney injury (CA-AKI) was more common than hospital-acquired acute kidney injury (HA-AKI) due to restricted elective surgeries during the COVID-19 pandemic. Acute kidney injury with multiorgan involvement and hepatic dysfunction, elderly age with higher SOFA score and sepsis were predictors of adverse renal and patient outcomes.

INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2023)

Article Medicine, General & Internal

Outcomes of COVID-19 patients with acute kidney injury and longitudinal analysis of laboratory markers during the hospital stay: A multi-center retrospective cohort experience from Pakistan

Muhammad Nadeem Ahsan et al.

Summary: The frequency and severity of acute kidney injury (AKI) in COVID-19 patients can affect the outcomes of the disease. A retrospective cohort study was conducted to evaluate the outcomes of hospitalized COVID-19 patients with AKI. The study found that AKI was common in this patient population, with a mortality rate of 27%.

MEDICINE (2023)

Review Urology & Nephrology

Risk factors for acute kidney injury in COVID-19 patients: an updated systematic review and meta-analysis

Jialing Zhang et al.

Summary: This meta-analysis aimed to identify risk factors for the development of acute kidney injury (AKI) in COVID-19 patients. The results showed that age, male sex, obesity, black race, invasive ventilation, and the use of diuretics, steroids and vasopressors, as well as comorbidities such as hypertension, congestive heart failure, chronic kidney disease, acute respiratory distress syndrome, and diabetes, were significant risk factors for COVID-19-associated AKI.

RENAL FAILURE (2023)

Article Urology & Nephrology

Prognostic significance of early acute kidney injury in COVID-19 patients requiring mechanical ventilation: a single-center retrospective analysis

Michal Sitina et al.

Summary: This study aimed to determine the prognostic significance of early acute kidney injury (AKI) in critically ill COVID-19 patients. The results showed that AKI on admission to the ICU and its development within the first 48 hours were associated with the need for renal replacement therapy (RRT) and increased mortality.

RENAL FAILURE (2023)

Article Urology & Nephrology

Prevalence and predictors of outcomes among ESRD patients with COVID-19

Claire S. Baptiste et al.

Summary: In emergency room patients, ESRD status was not associated with a higher risk of testing positive for COVID-19. Among COVID-positive ER patients, ESRD did not increase the risk of mortality, while insurance status had a strong and independent association with death.

BMC NEPHROLOGY (2023)

Article Urology & Nephrology

Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score

Henrique Palomba et al.

Summary: The study aimed to develop a prognostic score for predicting the development of Acute Kidney Injury (AKI) in COVID-19 patients. A retrospective observational study of 2334 COVID-19 patients admitted to 23 different hospitals in Brazil was conducted, and common clinical variables were found to accurately predict the development of AKI in these patients.

BMC NEPHROLOGY (2023)

Article Public, Environmental & Occupational Health

Global public health policies: gathering public health associations' perspectives

Liny Wilson et al.

Summary: This study aims to identify gaps and strengths in public health advocacy carried out by selected national public health associations between 2018 and 2021. The results show that while public health associations in high-income countries actively engage in advocacy, more efforts are needed to implement a more international and intersectoral approach at the global level, anchored in health as a human right and aligned with the Sustainable Development Goals.

GLOBAL HEALTH ACTION (2023)

Article Public, Environmental & Occupational Health

Colonization and decolonization of global health: which way forward?

Maysoon Hussain et al.

Summary: Despite the different names it has taken on throughout history, the field of global health still maintains colonialist structures. Colonial powers prioritized medical advancements for their own people, only considering locals when it benefited the colonies. The United States also relied on exploiting vulnerable populations for medical progress. This history is crucial in understanding the actions of the United States as a global health leader. However, the current global standard in the field fails to meet the needs of most of the world. The COVID-19 pandemic has highlighted the presence of colonial mentalities in global health partnerships, which can be counterproductive. Strategies for change have been questioned, particularly in terms of involving less privileged communities in shaping their own fate. Globally, there is a need to evaluate biases and learn from each other.

GLOBAL HEALTH ACTION (2023)

Article Public, Environmental & Occupational Health

The impact of COVID-19 and national pandemic responses on health service utilisation in seven low- and middle-income countries

Donald Fejfar et al.

Summary: The COVID-19 pandemic has disrupted health services worldwide, leading to increased mortality and secondary disease outbreaks. This study quantifies disruptions to outpatient services, facility-based deliveries, and family planning in seven low- and middle-income countries and examines the relationship between disruptions and the intensity of national pandemic responses.

GLOBAL HEALTH ACTION (2023)

Review Biotechnology & Applied Microbiology

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review

Pradipta Paul et al.

Summary: Despite widespread mass rollout programs, the effectiveness of existing vaccines against the SARS-CoV-2 Omicron variant is questioned. A systematic review comparing the effectiveness of COVID-19 vaccines reveals that primary vaccination provides inferior protection against Omicron compared to Delta and Alpha variants, and this protection wanes faster. However, mRNA vaccine boosters reestablish effectiveness to a certain extent against Omicron. Primary vaccination still offers strong protection against Omicron-associated hospitalization, severity, and death, while boosters provide more robust and longer-lasting protection against hospitalizations due to Omicron.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Article Transplantation

Results of the first nationwide cohort study of outcomes in dialysis and kidney transplant patients before and after vaccination for COVID-19

Julia Wijkstrom et al.

Summary: Kidney replacement therapy (KRT) patients in Sweden, who were prioritized for vaccination, experienced reduced hospitalization and mortality rates after vaccination, while kidney transplant recipients (KTRs) did not see the same reduction.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Medicine, General & Internal

Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel

Sebastian Mas-Fontao et al.

Journal of Clinical Medicine (2023)

Letter Urology & Nephrology

The severity of the second wave of SARS CoV-2 in maintenance dialysis patients of a single center in Brazil

Fernanda Salomao Gorayeb-Polacchini et al.

RENAL FAILURE (2022)

Article Urology & Nephrology

Patients receiving hemodialysis do not lose SARS-CoV-2 antibodies more rapidly than non-renal controls: a prospective cohort study

Ekaterina Parshina et al.

Summary: Patients receiving maintenance HD maintain significant long-term humoral and cellular immune responses following natural COVID-19.

RENAL FAILURE (2022)

Article Urology & Nephrology

Acid base disorders in patients with COVID-19

Gaetano Alfano et al.

Summary: The study found that acid-base disorders were common in COVID-19 patients, with metabolic alkalosis and respiratory alkalosis being the most frequent alterations. Patients with metabolic acidosis had a higher mortality rate.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

Article Cardiac & Cardiovascular Systems

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?

Vera Paar et al.

Summary: The study found that autologous serum and fibrin significantly increased the secretion of cytokines and chemokines, affecting the inflammatory response. Anti-coagulation may be a promising tool for the treatment of COVID-19, helping to reduce cytokine storm and thrombotic complications.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Letter Urology & Nephrology

COVID-19 in Peritoneal Dialysis Patients

Hua-Jun Jiang et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Hematology

COVID-19 in ESRD and Acute Kidney Injury

Jeroen P. Kooman et al.

Summary: The COVID-19 pandemic has had a significant impact on nephrology, with dialysis patients and those with COVID-19-related acute kidney injury being more susceptible to viral infection and disease progression, presenting challenges in treatment.

BLOOD PURIFICATION (2021)

Article Medicine, General & Internal

Role of serum albumin and proteinuria in patients with SARS-CoV-2 pneumonia

Cinzia Bassoli et al.

Summary: Hypoalbuminemia is common in patients with COVID-19 and is associated with inflammation markers and clinical outcomes. Proteinuria may serve as a potential biomarker for evaluating disease severity in COVID-19.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Article Transplantation

Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA

Alberto Ortiz et al.

Summary: Diabetes, hypertension, and cardiovascular disease have been traditionally considered risk factors for severe COVID-19, but recent studies have found that renal disease, especially dialysis, organ transplantation, and CKD, play a significant role in the mortality risk associated with COVID-19.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

Review Medical Laboratory Technology

Biomarkers for Prognosis and Treatment Response in COVID-19 Patients

Giulia Bivona et al.

Summary: Studies have shown that the levels of CRP and interleukin-6 are associated with disease severity in COVID-19 infections, but their clinical utility as biomarkers has not been proven.

ANNALS OF LABORATORY MEDICINE (2021)

Article Health Care Sciences & Services

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people

Laura Semenzato et al.

Summary: In France, the risk of COVID-19 hospitalization and mortality is associated with age, gender, social deprivation, and various chronic health conditions. Down syndrome, mental retardation, kidney transplantation, lung transplantation, end-stage renal disease, and active lung cancer show the strongest associations with COVID-19 risk.

LANCET REGIONAL HEALTH-EUROPE (2021)

Article Urology & Nephrology

Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection

Zijin Chen et al.

Summary: This study found a low incidence of acute kidney injury in non-ICU COVID-19 patients, with a higher risk in ICU patients. Factors associated with AKI included decreased platelet level, lower albumin level, lower phosphorus level, higher LDH level, procalcitonin, CRP, urea, and prothrombin time.

RENAL FAILURE (2021)

Editorial Material Public, Environmental & Occupational Health

Potential for global spread of a novel coronavirus from China

Isaac I. Bogoch et al.

JOURNAL OF TRAVEL MEDICINE (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Urology & Nephrology

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China

Fei Xiong et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Urology & Nephrology

Presentation and Outcomes of Patients with ESKD and COVID-19

Anthony M. Valeri et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Article Urology & Nephrology

Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia

Guangchang Pei et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Letter Urology & Nephrology

EPO in Patients With COVID-19: More Than an Erythropoietic Hormone

Jeremy Leventhal et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Article Urology & Nephrology

The clinical characteristics and course ofCOVID-19 in hemodialysis patients

Kubra Aydin Bahat et al.

HEMODIALYSIS INTERNATIONAL (2020)

Letter Urology & Nephrology

Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences

Osama El Shamy et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)

Editorial Material Urology & Nephrology

Acute peritoneal dialysis in COVID-19

Watanyu Parapiboon et al.

PERITONEAL DIALYSIS INTERNATIONAL (2020)

Editorial Material Physiology

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis

Alessandra F. Perna et al.

KIDNEY & BLOOD PRESSURE RESEARCH (2020)

Article Urology & Nephrology

Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans

Muner M. B. Mohamed et al.

KIDNEY360 (2020)

Review Medicine, General & Internal

Erythropoietin and Nonhematopoietic Effects

Alireza Nekoui et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)

Article Biochemistry & Molecular Biology

Heparin and anticoagulation

Akihiro Onishi et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2016)

Editorial Material Urology & Nephrology

KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease Foreword

Bertram L. Kasiske et al.

KIDNEY INTERNATIONAL SUPPLEMENTS (2013)

Article Respiratory System

Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury

R. MacRedmond et al.

EUROPEAN RESPIRATORY JOURNAL (2009)

Review Urology & Nephrology

Aspects of immune dysfunction in end-stage renal disease

Sawako Kato et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)